236 related articles for article (PubMed ID: 20739445)
1. Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.
van der Meij BS; Langius JA; Smit EF; Spreeuwenberg MD; von Blomberg BM; Heijboer AC; Paul MA; van Leeuwen PA
J Nutr; 2010 Oct; 140(10):1774-80. PubMed ID: 20739445
[TBL] [Abstract][Full Text] [Related]
2. Oral nutritional supplements containing n-3 polyunsaturated fatty acids affect quality of life and functional status in lung cancer patients during multimodality treatment: an RCT.
van der Meij BS; Langius JA; Spreeuwenberg MD; Slootmaker SM; Paul MA; Smit EF; van Leeuwen PA
Eur J Clin Nutr; 2012 Mar; 66(3):399-404. PubMed ID: 22234041
[TBL] [Abstract][Full Text] [Related]
3. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.
Fearon KC; Von Meyenfeldt MF; Moses AG; Van Geenen R; Roy A; Gouma DJ; Giacosa A; Van Gossum A; Bauer J; Barber MD; Aaronson NK; Voss AC; Tisdale MJ
Gut; 2003 Oct; 52(10):1479-86. PubMed ID: 12970142
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
[TBL] [Abstract][Full Text] [Related]
5. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
6. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA.
Patterson AC; Chalil A; Aristizabal Henao JJ; Streit IT; Stark KD
Nutr Res; 2015 Dec; 35(12):1040-51. PubMed ID: 26500082
[TBL] [Abstract][Full Text] [Related]
8. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.
Daud ZA; Tubie B; Adams J; Quainton T; Osia R; Tubie S; Kaur D; Khosla P; Sheyman M
Vasc Health Risk Manag; 2012; 8():187-95. PubMed ID: 22536073
[TBL] [Abstract][Full Text] [Related]
9. Nutrition intervention using an eicosapentaenoic acid (EPA)-containing supplement in patients with advanced colorectal cancer. Effects on nutritional and inflammatory status: a phase II trial.
Read JA; Beale PJ; Volker DH; Smith N; Childs A; Clarke SJ
Support Care Cancer; 2007 Mar; 15(3):301-7. PubMed ID: 17021855
[TBL] [Abstract][Full Text] [Related]
10. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
[TBL] [Abstract][Full Text] [Related]
11. The effects of an oral supplement enriched with fish oil, prebiotics, and antioxidants on nutrition status in Crohn's disease patients.
Wiese DM; Lashner BA; Lerner E; DeMichele SJ; Seidner DL
Nutr Clin Pract; 2011 Aug; 26(4):463-73. PubMed ID: 21775642
[TBL] [Abstract][Full Text] [Related]
12. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
[TBL] [Abstract][Full Text] [Related]
13. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults.
Thies F; Miles EA; Nebe-von-Caron G; Powell JR; Hurst TL; Newsholme EA; Calder PC
Lipids; 2001 Nov; 36(11):1183-93. PubMed ID: 11795850
[TBL] [Abstract][Full Text] [Related]
14. Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study.
Finocchiaro C; Segre O; Fadda M; Monge T; Scigliano M; Schena M; Tinivella M; Tiozzo E; Catalano MG; Pugliese M; Fortunati N; Aragno M; Muzio G; Maggiora M; Oraldi M; Canuto RA
Br J Nutr; 2012 Jul; 108(2):327-33. PubMed ID: 22114792
[TBL] [Abstract][Full Text] [Related]
15. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.
Barber MD; Ross JA; Voss AC; Tisdale MJ; Fearon KC
Br J Cancer; 1999 Sep; 81(1):80-6. PubMed ID: 10487616
[TBL] [Abstract][Full Text] [Related]
16. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
Cerchietti LC; Navigante AH; Castro MA
Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
[TBL] [Abstract][Full Text] [Related]
17. N-3 fatty acid EPA supplementation in cancer patients receiving abdominal radiotherapy - A randomised controlled trial.
Patursson P; Møller G; Muhic A; Andersen JR
Clin Nutr ESPEN; 2021 Jun; 43():130-136. PubMed ID: 34024504
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids.
James MJ; Ursin VM; Cleland LG
Am J Clin Nutr; 2003 May; 77(5):1140-5. PubMed ID: 12716664
[TBL] [Abstract][Full Text] [Related]
19. Preoperative oral supplementation with long-chain Omega-3 fatty acids beneficially alters phospholipid fatty acid patterns in liver, gut mucosa, and tumor tissue.
Senkal M; Haaker R; Linseisen J; Wolfram G; Homann HH; Stehle P
JPEN J Parenter Enteral Nutr; 2005; 29(4):236-40. PubMed ID: 15961678
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery.
Sorensen LS; Thorlacius-Ussing O; Schmidt EB; Rasmussen HH; Lundbye-Christensen S; Calder PC; Lindorff-Larsen K
Br J Surg; 2014 Jan; 101(2):33-42. PubMed ID: 24281905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
